Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
秦罗敷应助Daodao采纳,获得10
4秒前
崔崔发布了新的文献求助10
6秒前
7秒前
keyan123完成签到,获得积分10
7秒前
8秒前
11秒前
困困包发布了新的文献求助30
13秒前
冷艳的靳发布了新的文献求助10
14秒前
然12138发布了新的文献求助10
14秒前
15秒前
16秒前
天份z发布了新的文献求助10
17秒前
浮游应助开心采纳,获得10
21秒前
大芳儿发布了新的文献求助10
22秒前
Xjx6519发布了新的文献求助10
22秒前
浮游应助明亮紫易采纳,获得10
22秒前
24秒前
Tcell完成签到,获得积分10
29秒前
胡图图发布了新的文献求助10
29秒前
无极微光应助科研通管家采纳,获得20
30秒前
pluto应助科研通管家采纳,获得10
30秒前
科研通AI6应助科研通管家采纳,获得10
30秒前
shhoing应助科研通管家采纳,获得10
30秒前
李爱国应助科研通管家采纳,获得10
30秒前
乐乐应助科研通管家采纳,获得10
30秒前
JamesPei应助科研通管家采纳,获得10
30秒前
30秒前
玄风应助科研通管家采纳,获得10
30秒前
BowieHuang应助科研通管家采纳,获得10
30秒前
SciGPT应助科研通管家采纳,获得10
30秒前
张宇豪应助科研通管家采纳,获得10
30秒前
科研通AI6应助科研通管家采纳,获得10
31秒前
大模型应助科研通管家采纳,获得10
31秒前
田様应助科研通管家采纳,获得10
31秒前
玄风应助科研通管家采纳,获得10
31秒前
Verity应助科研通管家采纳,获得10
31秒前
厚朴应助开心采纳,获得10
32秒前
大龙哥886应助Xjx6519采纳,获得10
35秒前
在水一方应助zgsjymysmyy采纳,获得30
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1601
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 800
Biology of the Reptilia. Volume 21. Morphology I. The Skull and Appendicular Locomotor Apparatus of Lepidosauria 620
A Guide to Genetic Counseling, 3rd Edition 500
Laryngeal Mask Anesthesia: Principles and Practice. 2nd ed 500
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5557785
求助须知:如何正确求助?哪些是违规求助? 4642836
关于积分的说明 14669258
捐赠科研通 4584253
什么是DOI,文献DOI怎么找? 2514716
邀请新用户注册赠送积分活动 1488897
关于科研通互助平台的介绍 1459566